Adropin has been identified recently as a regulatory protein that participates in the regulation of energy homeostasis and insulin response [3].Kumar et al. observed adropin in mice and demonstrated that adropin has protective effects on cardiac system [4].Ertem et al. investigate the association between non-ST elevation myocardial infarction (NSTEMI) and serum adropin levels [5].
Patients with NSTEMI and high SYNTAX score had significantly lower serum adropin level (2357.30 pg/mL±821.58) compared to NSTEMI patients with low SYNTAX score (3077.00 pg/mL±912.86) and control group (3688.00±956.65).